GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Price-to-Tangible-Book

International Biotechnology Trust (LSE:IBT) Price-to-Tangible-Book : 0.82 (As of May. 25, 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Price-to-Tangible-Book?

As of today (2024-05-25), International Biotechnology Trust's share price is £6.12. International Biotechnology Trust's Tangible Book per Share of Feb. 2024 for the quarter that ended in Feb. 2024 was £7.49. Hence, International Biotechnology Trust's Price to Tangible Book Ratio of today is 0.82.

The historical rank and industry rank for International Biotechnology Trust's Price-to-Tangible-Book or its related term are showing as below:

LSE:IBT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.79   Med: 0.94   Max: 1.02
Current: 0.82

During the past 13 years, International Biotechnology Trust's highest Price to Tangible Book Ratio was 1.02. The lowest was 0.79. And the median was 0.94.

LSE:IBT's Price-to-Tangible-Book is ranked better than
72.66% of 1624 companies
in the Asset Management industry
Industry Median: 0.96 vs LSE:IBT: 0.82

A closely related ratio is called PB Ratio. As of today, International Biotechnology Trust's share price is £6.12. International Biotechnology Trust's Book Value per Sharefor the quarter that ended in Feb. 2024 was £7.49. Hence, International Biotechnology Trust's P/B Ratio of today is 0.82.


International Biotechnology Trust Price-to-Tangible-Book Historical Data

The historical data trend for International Biotechnology Trust's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Price-to-Tangible-Book Chart

International Biotechnology Trust Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 0.99 0.93 0.93 0.94

International Biotechnology Trust Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 0.93 0.95 0.94 0.91

Competitive Comparison of International Biotechnology Trust's Price-to-Tangible-Book

For the Asset Management subindustry, International Biotechnology Trust's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's Price-to-Tangible-Book Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, International Biotechnology Trust's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Price-to-Tangible-Book falls into.



International Biotechnology Trust Price-to-Tangible-Book Calculation

International Biotechnology Trust's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Feb. 2024 )
=6.12/7.489
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


International Biotechnology Trust Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines